ZTS
Zoetis Inc - Class A
DRUG MANUFACTURERS - SPECIALTY & GENERIC · HEALTHCARE
Zoetis Inc. (ZTS) stands as a premier global leader in animal health, focusing on the innovation and manufacturing of pharmaceuticals and vaccines for livestock and companion animals alike. Leveraging a robust portfolio backed by advanced research, Zoetis addresses the critical demands of animal agr...
$83.18
+4.34% (+$3.46)
Volume
5.42M
52W High
$144.83
52W Low
$68.77
Market Cap
$34.29B
What to Watch This Quarter
Based on historical dataConsensus EPS
$1.51
Whisper EPS
$1.39
8.1% below consensus
Last Quarter
--
Current Streak
1 Beat
Avg Surprise (4Q)
-1.96%
Next Earnings Report
Price Chart
EPS History: Consensus vs Actual
Last 10 quartersPrice Movement Around Earnings
Q2 2026
Aug 6, 2026
1-Day:
-5.97%
5-Day:
-2.48%
Q2 2026
Aug 4, 2026
1-Day:
-2.17%
Q1 2026
May 7, 2026
1-Day:
-5.13%
5-Day:
-11.88%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q2'26 | $2.47B | +0.3% | 72.7% | 38.0% | $691.0M |
| Q1'26 | $2.26B | +1.9% | 71.7% | 36.3% | $601.0M |
| Q4'25 | $2.39B | +3.0% | 68.9% | 34.6% | $603.0M |
| Q3'25 | $2.40B | +0.5% | 70.2% | 39.0% | $721.0M |
| Q2'25 | $2.46B | +4.2% | 72.3% | 40.2% | $718.0M |
| Q1'25 | $2.22B | +1.4% | 70.5% | 38.1% | $631.0M |
| Q4'24 | $2.32B | +4.7% | 68.0% | 33.0% | $581.0M |
| Q3'24 | $2.39B | +11.0% | 69.2% | 38.5% | $682.0M |
Company Information
Symbol
ZTS
Company
Zoetis Inc - Class A
Market Cap
$34.29B
Sector
HEALTHCARE
Next Earnings
Nov 5, 2026
Also Reporting Soon
Companies reporting earnings around the same time as ZTS
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - SPECIALTY & GENERIC
Compare ZTS with competitors
Side-by-side earnings comparison